Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 9
2003 12
2004 20
2005 21
2006 15
2007 15
2008 20
2009 25
2010 17
2011 27
2012 35
2013 35
2014 41
2015 58
2016 48
2017 67
2018 73
2019 82
2020 129
2021 120
2022 128
2023 132
2024 145
2025 170
2026 117

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,369 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean yu shan (871 results)?
Precision treatment with artificial intelligence assisted subtyping enhances therapeutic efficacy in HR+/HER2- breast cancer: The LINUXtrial.
Fan L, Zhang WJ, Li HP, Zeng XH, Teng YE, Gong Y, Jin X, Zhao S, Sun T, Chen WY, Wang SS, Yang J, Zhuang ZG, Ni SJ, He ZX, Fu DY, Song CG, Lv Z, Liang QN, Yu BH, Shi J, Wang N, Liang XR, Zhang NN, Wang Y, Ji P, Liu XY, Chen L, He M, Liu Y, Sui XY, Ma LX, Zhu XZ, Yang F, Ge LP, Wu SY, Wu J, Yu KD, Liu GY, Hu X, Shen Y, Pang Z, Wang JF, Liang F, Yang WT, Wang ZH, Jiang YZ, Shao ZM; BCTOP investigators. Fan L, et al. Among authors: shen y. Cancer Cell. 2026 Feb 9;44(2):355-365.e3. doi: 10.1016/j.ccell.2025.11.003. Epub 2025 Dec 4. Cancer Cell. 2026. PMID: 41349543 Clinical Trial.
Camrelizumab vs Placebo in Combination With Chemotherapy as Neoadjuvant Treatment in Patients With Early or Locally Advanced Triple-Negative Breast Cancer: The CamRelief Randomized Clinical Trial.
Chen L, Li H, Zhang H, Yang H, Qian J, Li Z, Ren Y, Wang S, Fu P, Yang H, Liu Y, Sun J, Nie J, Lei R, Yao Y, Zhang A, Wang S, Ma X, Ouyang Z, Yang H, Wu SY, Cao SW, Wang K, Jiang A, Ouyang Q, Pang D, Wei L, Zha X, Shen Y, Qu X, Wu F, Zhu X, Wang Z, Fan L, Shao ZM. Chen L, et al. Among authors: shen y. JAMA. 2025 Feb 25;333(8):673-681. doi: 10.1001/jama.2024.23560. JAMA. 2025. PMID: 39671272 Free PMC article. Clinical Trial.
Selective Elimination of Breast Surgery for Invasive Breast Cancer: A Nonrandomized Clinical Trial.
Kuerer HM, Valero V, Smith BD, Krishnamurthy S, Diego EJ, Johnson HM, Lin H, Shen Y, Lucci A, Shaitelman SF, Mitchell MP, Boughey JC, White RL, Hunt KK, Yang WT, Rauch GM; Exceptional Responders Study Group. Kuerer HM, et al. Among authors: shen y. JAMA Oncol. 2025 May 1;11(5):529-534. doi: 10.1001/jamaoncol.2025.0207. JAMA Oncol. 2025. PMID: 40152443 Free PMC article. Clinical Trial.
Safety, Efficacy, and Pharmacokinetics of SHR-A1811, a Human Epidermal Growth Factor Receptor 2-Directed Antibody-Drug Conjugate, in Human Epidermal Growth Factor Receptor 2-Expressing or Mutated Advanced Solid Tumors: A Global Phase I Trial.
Yao H, Yan M, Tong Z, Wu X, Ryu MH, Park JJ, Kim JH, Zhong Y, Zhao Y, Voskoboynik M, Yin Y, Liu K, Kaubisch A, Liu C, Zhang J, Wang S, Im SA, Ganju V, Barve M, Li H, Ye C, Roy AC, Bai LY, Yen CJ, Gu S, Lin YC, Wu L, Bao L, Zhao K, Shen Y, Rong S, Zhu X, Song E. Yao H, et al. Among authors: shen y. J Clin Oncol. 2024 Oct 10;42(29):3453-3465. doi: 10.1200/JCO.23.02044. Epub 2024 Jun 20. J Clin Oncol. 2024. PMID: 38900984 Clinical Trial.
Small-molecule inhibition of YTHDC1 as a strategy against acute myeloid leukemia in mouse models.
Zhang H, Li Y, Zhao Y, Wang F, Lin G, Niu T, Li H, Li Y, Liu L, Liang Y, Shen Y, Yi Y, Zhou H, Lou S, Ye Y, He Y, Yang R, Yao R, Tian C, Zhou P, Wu M, Chen M, Xu H, You J, Liao Y, Yang C, Zhao A, Chen C, Li L, Pei S, Yang S. Zhang H, et al. Among authors: shen y. Sci Transl Med. 2026 Feb 4;18(835):eadu3137. doi: 10.1126/scitranslmed.adu3137. Epub 2026 Feb 4. Sci Transl Med. 2026. PMID: 41637525
1,369 results